AFR
Mesoblast shares slump ahead of FDA meetingWilliam McInnes
Mesoblast's shares have slumped in early trade ahead of a scheduled meeting with the US Food and Drug Administration on Thursday.
Its shares are down 13.1 per cent to $4.23, having dropped as much as 19 per cent earlier.
In a briefing note released by the FDA ahead of the meeting, the Oncologic Drugs Advisory Committee (ODAC) appears to have cast some doubt on Mesoblast's Remestemcel-L candidate.
"FDA’s position is that the product attributes the Applicant has identified as related to potency and activity, however, do not have a demonstrated relationship to the clinical performance of specific DP lots, and that the product’s proposed immunomodulatory mechanism of action has not been demonstrated in vivo in study subjects receiving remestemcel-L," it said.
"Without a demonstrated relationship with clinical effectiveness and/or in vivo potency/activity, controlling these CQAs may not be sufficient to ensure the manufacturing process consistently produces remestemcel-L lots of acceptable quality."
- Forums
- ASX - By Stock
- MSB
- MSB Trading - Aug 2020 on
MSB Trading - Aug 2020 on, page-679
-
- There are more pages in this discussion • 1,706 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
-0.035(3.13%) |
Mkt cap ! $1.255B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.04 | $12.82M | 11.89M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 123878 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 26626 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 111254 | 1.080 |
27 | 62761 | 1.075 |
11 | 113789 | 1.070 |
11 | 174342 | 1.065 |
9 | 99221 | 1.060 |
Price($) | Vol. | No. |
---|---|---|
1.085 | 28845 | 15 |
1.090 | 120816 | 15 |
1.095 | 95145 | 14 |
1.100 | 115529 | 9 |
1.105 | 185323 | 9 |
Last trade - 15.01pm 09/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |